Related Experiment Video
Updated: Dec 10, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Ivermectin: Potential Role as Repurposed Drug for COVID-19
Alok Dixit1, Ramakant Yadav2, Amit Vikram Singh1
1Department of Pharmacology, Uttar Pradesh University of Medical Sciences, Uttar Pradesh, India.
This study explores repurposed drugs for COVID-19, focusing on ivermectin (IVM) as a potential therapeutic option. It highlights the need for rapid response measures during the pandemic.
Area of Science:
- Virology
- Infectious Diseases
- Pharmacology
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, a highly communicable disease declared a pandemic by the WHO.
- Limited understanding of SARS-CoV-2 pathogenesis and proliferation necessitates rapid therapeutic strategies.
- Development of novel vaccines and drugs is ongoing but requires significant time for safety and efficacy testing.
Purpose of the Study:
- To review currently used repurposed drugs for COVID-19 treatment.
- To evaluate the potential of ivermectin (IVM) as a therapeutic option for COVID-19.
- To discuss rapid response measures for the ongoing pandemic.
Main Methods:
- Literature review of existing repurposed drugs for COVID-19.
- Analysis of scientific data regarding the potential efficacy and safety of ivermectin (IVM).
- Discussion of ivermectin's role as a repurposed therapeutic agent.
Main Results:
- Several existing drugs are being repurposed for COVID-19 treatment.
- Ivermectin (IVM) shows potential as a therapeutic option, warranting further investigation.
- Repurposing drugs with established safety profiles offers a rapid response to the pandemic.
Conclusions:
- Repurposing existing drugs is a crucial strategy for managing the COVID-19 pandemic.
- Ivermectin (IVM) presents a promising therapeutic avenue for COVID-19.
- Continued research into repurposed agents is essential for effective pandemic response.
More Related Videos
04:28Utilizing an Orally Dissolving Strip for Pharmacological and Toxicological Studies: A Simple and Humane Alternative to Oral Gavage for Animals
Published on: March 23, 2016
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Antimicrobial Effectiveness
Heart Failure Drugs: Inotropic Agents
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Pharmacokinetics: Drug–Food and Drug–Viral Interactions